TUCSON, Ariz., March 22, 2017 -- In the age of “evidence-based medicine,” why not use the scientific method to compare economic systems, suggests David Legates in the spring issue of the Journal of American Physicians and Surgeons.
The experiment of destroying a country by war; dividing it into two parts similar in culture, population, climate, and geography; and then rebuilding one part under a capitalist and one part under a socialist system has already been done—twice, Legates writes. He looks at the results in East and West Germany, and North and South Korea.
At the time of the unexpected reunification in 1989 after 45 years, productivity in East Germany was 70 percent of that in the West. Life expectancy was about 3 years shorter, and the price of luxury items and most staples was much higher in the East, Legates reports.
The Korean experiment has been in progress for more than 60 years. The North is mired in abject poverty, while the South thrives as one of the world’s major G-20 economies. Life expectancy is 10 years shorter in the North, Legates notes.
Medical ethics are vastly different in the capitalist and socialist sides, reflecting the roles of the individual versus the state, Legates explains, using examples of the care of the aging, unconsented drug treatment of East German and North Korean athletes, and possibly secret pharmaceutical research on unknowing subjects in East Germany.
Among the most profound differences is the environmental degradation in the socialist systems, Legates states, “In 1990, Greenpeace labeled Bitterfeld, East Germany, as ‘the dirtiest place in the most polluted country in the world.’”
“The key ingredient that separated West from East Germany and still separates South from North Korea is freedom,” Legates concludes.
The Journal of American Physicians and Surgeons is published by the Association of American Physicians and Surgeons (AAPS), a national organization representing physicians in all specialties since 1943.
Contact: David [email protected], or Jane M. Orient, M.D., (520) 323-3110, [email protected]


Aktis Oncology Prices Upsized IPO at $18, Raising $318 Million in Major Biotech Debut
Walmart to Join Nasdaq-100 Index as It Replaces AstraZeneca Following Exchange Move
Nvidia Appoints Former Google Executive Alison Wagonfeld as First Chief Marketing Officer
Rio Tinto–Glencore Merger Talks Spark Investor Debate Over Value, Strategy and Coal Exposure
China’s AI Sector Pushes to Close U.S. Tech Gap Amid Chipmaking Challenges
UBS Upgrades L’Oréal to Buy, Sees Strong Sales Momentum and 20% Upside
Vitol to Ship First U.S. Naphtha Cargo to Venezuela Under New Oil Supply Deal
FTC Blocks Edwards Lifesciences’ JenaValve Acquisition in Major Antitrust Ruling
Supreme Court to Hear Cisco Appeal on Alien Tort Statute and Human Rights Liability
Allegiant to Acquire Sun Country Airlines in $1.5 Billion Deal to Expand U.S. Leisure Travel Network
Johnson & Johnson Secures Tariff Exemption by Agreeing to Lower Drug Prices in the U.S.
Trump Calls for 10% Credit Card Interest Rate Cap Starting 2026
Elon Musk Says X Will Open-Source Its Algorithm Amid EU Scrutiny
xAI Cash Burn Highlights the High Cost of Competing in Generative AI
BESI Reports Strong Q4-25 Orders Surge Driven by Data Center and Hybrid Bonding Demand
Hanwha Ocean Shares Rise on Plans to Expand U.S. Shipbuilding Capacity
GM Takes $6 Billion EV Write-Down as Electric Vehicle Demand Slows in the U.S. 



